2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $238M | $458M | $677M | $730M | $736M |
Cost of Revenue | $187M | $275M | $420M | $406M | $66M |
Gross Profit | $51M | $184M | $257M | $324M | $669M |
Gross Profit % | 22% | 40% | 38% | 44% | 91% |
R&D Expenses | -$0.82 | -$0.13 | -$0.0029 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$125M | -$43M | -$9.1M | $15M | -$7.8M |
Dep. & Amort. | $75M | $72M | $67M | $67M | $68M |
Def. Tax | -$39M | -$16M | $7M | $5.6M | $0 |
Stock Comp. | $4.4M | $9.3M | $8.2M | $6.4M | $8.2M |
Chg. in WC | -$16M | $16M | $23M | $5.3M | $13M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $6.7M | $18M | $22M | $56M | $41M |
ST Investments | $1.4M | $4.6M | $3.9M | $5.4M | $8.1M |
Cash & ST Inv. | $6.7M | $18M | $22M | $61M | $41M |
Receivables | $405K | $31M | $6.7M | $7.6M | $21M |
Inventory | $3.4M | $4.9M | $5.7M | $5.9M | $0 |
MCS reported strong year-over-year improvement in Q4 FY2024, with consolidated revenues of $188M, a 16% increase, and adjusted EBITDA of $26M, a 42% increase over the prior year.
The theater division saw a 23% revenue increase in Q4, driven by a stronger film slate and attendance growth of nearly 30%, though average ticket prices decreased due to value-oriented promotions.
The hotels and resorts division achieved record revenue and adjusted EBITDA for FY2024, with RevPAR growth of 3.6% in Q4 and continued strength in group business despite some renovation-related impacts.
For FY2025, MCS expects capital expenditures of $70M-$85M, with significant investments in hotel renovations and theater enhancements, alongside a focus on long-term attendance growth through programs like the Marcus Movie Club.
The company anticipates low to mid-single-digit RevPAR growth in FY2025 for its hotels and modestly increasing wide film releases in theaters, with optimism for strong growth in FY2025 and FY2026 based on the film slate.